This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Luo, H. Articles by Yang, D. Search for Related Content PubMed PubMed Citation Articles by Luo, H. Articles by Yang, D.

(American Journal of Pathology. 2003;163:381-385.)
© 2003 American Society for Investigative Pathology

Short Communication

Proteasome Inhibition Reduces Coxsackievirus B3 Replication in Murine Cardiomyocytes

From the McDonald Research Laboratories/The iCAPTUR⁴E Center, Department of Pathology and Laboratory Medicine, St. Paul’s Hospital/Providence Health Care, University of British Columbia, Vancouver, British Columbia, Canada

Coxsackievirus is the most prevalent virus associated with the pathogenesis of myocarditis and its sequela dilated cardiomyopathy. We have previously shown that coxsackievirus infection facilitates the ubiquitin/proteasome processing of the cell-cycle protein cyclin D1 and the tumor suppressor p53, which raises the possibility that the ubiquitin/proteasome pathway may be used by virus to promote viral replication. In this study, we examined the interplay between coxsackievirus replication and the ubiquitin/proteasome pathway in murine cardiomyocytes. We found that treatment of cells with the proteasome inhibitors MG132 or lactacystin significantly decreased virus titers in the supernatant and prevented virus-induced cell death. We further examined the effects of proteasome inhibitor on different stages of coxsackievirus life-cycle. We showed that inhibition of the ubiquitin/proteasome pathway did not affect virus entry and had no influence on viral protease proteolytic activities. However, viral RNA transcription and protein translation were markedly reduced after addition of proteasome inhibitors. We further demonstrate that ubiquitin/proteasome pathway-mediated viral replication does not appear to be related to changes in proteasome activities. Taken together, our data suggest that proteasome inhibitor reduces coxsackievirus replication through inhibition of viral RNA transcription and protein synthesis. Thus, proteasome inhibition may represent a novel therapeutic approach against myocarditis.

This article has been cited by other articles:

				X. Si, Y. Wang, J. Wong, J. Zhang, B. M. McManus, and H. Luo Dysregulation of the Ubiquitin-Proteasome System by Curcumin Suppresses Coxsackievirus B3 Replication J. Virol., April 1, 2007; 81(7): 3142 - 3150. [Abstract] [Full Text] [PDF]

				G. Szalay, S. Meiners, A. Voigt, J. Lauber, C. Spieth, N. Speer, M. Sauter, U. Kuckelkorn, A. Zell, K. Klingel, et al. Ongoing Coxsackievirus Myocarditis Is Associated with Increased Formation and Activity of Myocardial Immunoproteasomes Am. J. Pathol., May 1, 2006; 168(5): 1542 - 1552. [Abstract] [Full Text] [PDF]

				X. Si, B. M. McManus, J. Zhang, J. Yuan, C. Cheung, M. Esfandiarei, A. Suarez, A. Morgan, and H. Luo Pyrrolidine Dithiocarbamate Reduces Coxsackievirus B3 Replication through Inhibition of the Ubiquitin-Proteasome Pathway J. Virol., July 1, 2005; 79(13): 8014 - 8023. [Abstract] [Full Text] [PDF]

				J. Yuan, P. K. M. Cheung, H. M. Zhang, D. Chau, and D. Yang Inhibition of Coxsackievirus B3 Replication by Small Interfering RNAs Requires Perfect Sequence Match in the Central Region of the Viral Positive Strand J. Virol., February 15, 2005; 79(4): 2151 - 2159. [Abstract] [Full Text] [PDF]

				P. Tajmir, R. B. Ceddia, R.-K. Li, I. R. Coe, and G. Sweeney Leptin Increases Cardiomyocyte Hyperplasia via Extracellular Signal-Regulated Kinase- and Phosphatidylinositol 3-Kinase-Dependent Signaling Pathways Endocrinology, April 1, 2004; 145(4): 1550 - 1555. [Abstract] [Full Text] [PDF]